case 3: pd-l1 testing used in triple-negative breast cancer
Published 4 years ago • 414 plays • Length 3:37Download video MP4
Download video MP3
Similar videos
-
1:17
3disc | scan&tell preleminary examination
-
1:36:02
mesa 3 razonamiento probatorio
-
5:39
hematology: clearing error codes from the mindray bc 3200 part 2
-
1:14
capillarys 3 tera - sebia
-
13:45
perbaikan hematologi mindray bc-3200 wbc clog dan baground abnormal
-
5:01
cara qc alat hematology tecom 3 diff.
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
6:31
z3 crp hematology analyzer operation guide zybio
-
1:46
preclinical efficacy of the pkcβ inhibitor ms-553 in btki resistant cll
-
19:54
laparoscopic surgery adbominal access- description, indications and questions
-
3:20
phase i trial of a bcma-cd3 bispecific antibody in r/r myeloma
-
4:12
cmp sobre fallo judicial de la píldora anticonceptiva de emergencia
-
3:29
bd chloraprep™ in-service video - 1ml, 3 ml, & frepp
-
1:16
dll3/cd3 bispecific antibody: mechanism of action
-
1:26
preclinical safety and efficacy of cd123-nk cell engager in r/r aml
-
2:58
dislipidemia: medidas no farmacológicas
-
1:08:39
derecho procesal penal 3
-
2:50
rp11-438n5.3 as a novel biomarker in nsclc - video abstract [id 237024]
-
1:39
research that sheds light on the mechanism of action of pml in triple negative breast cancer
-
1:05
phase i/ii study of ms-553, a selective pkc-ß inhibitor, in patients with cll and sll
-
1:20
regulation of tetraspanin cd63 in cml progression: single-cell analysis of asymmetric hsc division